Blue Flower

External News Links

The CDC Proposed a guideline for Opiate prescriptions for chronic pain and includes provisions for drug testing all pain patients.  You can comment on the proposed guidelines, the comments are open until January 13th.  The following link will bring you to the comment site!submitComment;D=CDC-2015-0112-0001.  Please note that many pain clinics already drug test and remove patients for using marihuana due to pressure from the DEA (Drug Enforcement Agency).

The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain public comment on the draft CDC Guideline for Prescribing Opioids for Chronic Pain (Guideline). The Guideline provides recommendations regarding initiation or continuation of opioids for chronic pain; opioid selection, dosage, duration, follow-up, and discontinuation; and assessment of risk and addressing harms of opioid use. The Guideline is intended to be used by primary care providers (e.g., family physicians or internists) who are treating patients with chronic pain (i.e., pain lasting longer than 3 months or past the time of normal tissue healing) in outpatient settings. The draft Guideline is intended to apply to patients aged 18 years of age or older with chronic pain outside of palliative and end-of-life care. The Guideline is not intended to apply to patients in treatment for active cancer. The Guideline is not a federal regulation; adherence to the Guideline will be voluntary. See more at

You can also see the CDC's factsheet at

My comment Tracking Number is  1k0-8n9r-i78v, OPN strongly suggest you to add your own comments and encourage CDC to acknowledge mariihuana's positive role in reducing or eliminating the need for opioids in effective pain control.